INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Core Viewpoint - Inspire Medical Systems, Inc. is facing a class action lawsuit for securities fraud due to misleading statements regarding the launch of its Inspire V product, which did not meet market expectations [5]. Group 1: Lawsuit Details - The Schall Law Firm is leading a class action lawsuit against Inspire Medical Systems for violations of the Securities Exchange Act of 1934 [1]. - Investors who purchased securities between August 6, 2024, and August 4, 2025, are encouraged to contact the firm before January 5, 2026 [2]. - The class has not yet been certified, meaning potential participants are not yet represented by an attorney [4]. Group 2: Allegations Against the Company - The lawsuit claims that Inspire made false and misleading statements about its preparedness for the Inspire V launch, which was actually met with weak demand [5]. - The company allegedly ignored essential steps to ensure quick adoption of the new device by clinicians, leading to materially misleading public statements throughout the class period [5]. - As a result of the revelations about the company's performance, investors reportedly suffered damages [5].